- Home
- NCSM vs XTNT Comparison
NCSM vs XTNT Comparison
Compare NCSM & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- XTNT
- Stock Information
- Founded
- NCSM 2006
- XTNT N/A
- Country
- NCSM United States
- XTNT United States
- Employees
- NCSM N/A
- XTNT N/A
- Industry
- NCSM Oilfield Services/Equipment
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NCSM Energy
- XTNT Health Care
- Exchange
- NCSM Nasdaq
- XTNT Nasdaq
- Market Cap
- NCSM 61.1M
- XTNT 60.9M
- IPO Year
- NCSM 2017
- XTNT N/A
- Fundamental
- Price
- NCSM $31.44
- XTNT $0.50
- Analyst Decision
- NCSM
- XTNT Strong Buy
- Analyst Count
- NCSM 0
- XTNT 1
- Target Price
- NCSM N/A
- XTNT $3.00
- AVG Volume (30 Days)
- NCSM 9.5K
- XTNT 125.2K
- Earning Date
- NCSM 04-30-2025
- XTNT 05-12-2025
- Dividend Yield
- NCSM N/A
- XTNT N/A
- EPS Growth
- NCSM N/A
- XTNT N/A
- EPS
- NCSM 3.27
- XTNT N/A
- Revenue
- NCSM $168,704,000.00
- XTNT $117,267,000.00
- Revenue This Year
- NCSM $7.03
- XTNT $11.64
- Revenue Next Year
- NCSM $5.82
- XTNT $7.59
- P/E Ratio
- NCSM $9.66
- XTNT N/A
- Revenue Growth
- NCSM 18.16
- XTNT 28.44
- 52 Week Low
- NCSM $15.90
- XTNT $0.33
- 52 Week High
- NCSM $38.95
- XTNT $0.88
- Technical
- Relative Strength Index (RSI)
- NCSM 52.40
- XTNT 53.96
- Support Level
- NCSM $29.15
- XTNT $0.39
- Resistance Level
- NCSM $32.71
- XTNT $0.54
- Average True Range (ATR)
- NCSM 1.84
- XTNT 0.05
- MACD
- NCSM 0.26
- XTNT 0.01
- Stochastic Oscillator
- NCSM 38.99
- XTNT 76.47
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.